[MEDIA] [MEDIA] [MEDIA] [MEDIA]
I'm happy that we're finally getting a taste of 21st century science, as well as a comparison with other fatiguing illnesses which smaller ME/CFS...
Case in point: I don't know why Clare Gerada is rushing to reply to tweets about her claims on the BBC Breakfast program, if she didn't think this...
@dave30th This isn't psychosocial research but a short letter to the editor could easily debunk their claims.
They didn't look at post-exertional malaise, the term doesn't appear once in the text. They didn't separate participants into ME only, FM only, or...
[MEDIA] [MEDIA] Truly the Wessely school -- throwing people with ME under the bus while passing off scientific criticism as personal abuse. She...
Both. She's been blocking individual accounts, including ME patients who haven't interacted with her.
But strangely they do not mention risk of bias when they discuss the limitation of assessing RCTs at the review level: This is unfortunate....
@Hutan picked up important fallacies about testing. Though, on the point that the "Symptoms Clinic" wouldn't save the expense of tests done prior...
The European resolution on ME/CFS emphasizes the need for biomedical research specifically (points 6 and 7) and asks that it be funded through...
The dose is important, yes. My impression is that even moderate people can tolerate a glass of wine if not a little more, so a higher dose of...
One question that has been bugging my mind is whether studying the lowered tolerance to alcohol that is commonly reported in ME would yield...
This article seems to have worrying implications because, earlier this year, some ME/CFS research teams had to freeze fresh blood samples before...
The dichotomy between objective and subjective outcome measures that Stokes & Wade attempt to set up here is a false one. Objective outcome...
The history of ME/CFS is rather well described. However, the article is very speculative and I am especially concerned with the claims that are...
MDPI has been criticized but they seem to be a decent publisher. Their selling point seems to be fast review. Here is an article that looks...
Watching from outside the UK, we are very happy that NICE is coming to reason (and not “came” until the release of the final guidelines) thanks to...
When the authors uploaded their pre-print to medRxiv on July 30th, I sent the following mail to Dr Townsend: I received a reply within the next...
ME Action have written a letter with 19 questions ahead of the meeting:...
Dr Pierre Tattevin is the president of the French Society of Infectious Pathology (SPILF), which scientific journalists in France generally side...
Separate names with a comma.
